HUNTSVILLE, Ala. — If you've bought health or beauty products recently at Family Dollar stores, check your shelves and check this list. More than 250 items are being recalled because, according to the FDA, they were "stored outside of labeled temperature requirements by Family Dollar and inadvertently shipped to certain stores." Some of those items? Toothpastes, laxatives, and children's cold medicine.
The FDA says that the recalled items were shipped to certain stores in 23 states from June 1, 2023 through September 21, 2023 and sold until October 4, 2023. The agency says that Family Dollar has not received any consumer complaints or reports of illness and that the recall "is being conducted out of an abundance of caution." Not all products went to all stores.
BELOW: List of recalled products
In its statement, the FDA said:
Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product. Customers who purchased affected product may return such product to the Family Dollar store where they were purchased without receipt. This recall only applies to the following 23 states as no Family Dollar stores in any of the other states received any products subject to this recall: AL, AR, AZ, CA, CO, FL, GA, ID, KS, LA, MS, MT, ND, NE, NM, NV, OK, OR, SD, TX, UT, WA, and WY.
Customers with questions regarding this recall may contact Family Dollar Customer Service at 844-636-7687 between 9 a.m. and 5 p.m. EST. Customers should contact their physician or health care provider if they have experienced any problems that may be related to using these products.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
